Frontlight ResearchEarly access
Trial site
Hull University Teaching Hospitals NHS Trust
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- BioNTech SE2 trials
- Gilead Sciences1 trial
- Icahn School of Medicine at Mount Sinai1 trial
- Imperial College London1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Recruiting
Active, not recruiting
Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026